Black Diamond Therapeutics (BDTX) ROA US GAAP (year values) |
|||||||||
2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
ROA, % | ? | -26.0% | -19.9% | -49.7% | -54.1% | -52.0% | -53.0% | ||
Changes by years, y/y, % | -9pp | +6pp | -30pp | -4pp | +2pp | +24.7% |
Black Diamond Therapeutics. ROA, %
Black Diamond Therapeutics. ROA, changes, pp
Black Diamond Therapeutics (BDTX) ROA US GAAP (quarter values) |
||||||||
2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
ROA, % | ? | -46.1% | -51.6% | -56.0% | -53.7% | -53.0% | -53.0% | |
Changes by years, y/y, % | -133pp | +3pp | +3pp | +11pp | -7pp | |||
Changes by quarters, q/q, % | +18pp | -5pp | -4pp | +2pp | +1pp |